JP2006219454A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006219454A5 JP2006219454A5 JP2005036235A JP2005036235A JP2006219454A5 JP 2006219454 A5 JP2006219454 A5 JP 2006219454A5 JP 2005036235 A JP2005036235 A JP 2005036235A JP 2005036235 A JP2005036235 A JP 2005036235A JP 2006219454 A5 JP2006219454 A5 JP 2006219454A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- therapeutic
- prophylactic agent
- dgla
- skin disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 claims 11
- 230000000069 prophylactic effect Effects 0.000 claims 9
- 230000001225 therapeutic effect Effects 0.000 claims 9
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 claims 8
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 claims 8
- 208000017520 skin disease Diseases 0.000 claims 6
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 125000005456 glyceride group Chemical group 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 claims 1
- 229930186217 Glycolipid Natural products 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 235000021588 free fatty acids Nutrition 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 125000005457 triglyceride group Chemical group 0.000 claims 1
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005036235A JP5546087B2 (ja) | 2005-02-14 | 2005-02-14 | 皮膚疾患経口治療または予防剤 |
| CA2599112A CA2599112C (en) | 2005-02-14 | 2006-02-10 | Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient |
| EP19183855.6A EP3581178B1 (en) | 2005-02-14 | 2006-02-10 | Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient |
| US11/884,199 US9006287B2 (en) | 2005-02-14 | 2006-02-10 | Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient |
| PCT/JP2006/302787 WO2006085687A1 (ja) | 2005-02-14 | 2006-02-10 | ジホモ−γ−リノレン酸（ＤＧＬＡ）を有効成分として含んで成る組成物 |
| EP06713928.7A EP1852114B1 (en) | 2005-02-14 | 2006-02-10 | Composition containing dihomo-y-linolenic acid (dgla) as active ingredient |
| CN 200610003112 CN101019853B (zh) | 2005-02-14 | 2006-02-14 | 含有有效成分二均-γ-亚麻酸(DGLA)的组成物 |
| CN2012100164426A CN102600174A (zh) | 2005-02-14 | 2006-02-14 | 含有有效成分二均-γ-亚麻酸(DGLA)的组成物 |
| US14/644,231 US9943495B2 (en) | 2005-02-14 | 2015-03-11 | Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient |
| US15/911,806 US10342773B2 (en) | 2005-02-14 | 2018-03-05 | Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005036235A JP5546087B2 (ja) | 2005-02-14 | 2005-02-14 | 皮膚疾患経口治療または予防剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012013311A Division JP2012082226A (ja) | 2012-01-25 | 2012-01-25 | 皮膚疾患経口治療または予防剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006219454A JP2006219454A (ja) | 2006-08-24 |
| JP2006219454A5 true JP2006219454A5 (enExample) | 2008-03-27 |
| JP5546087B2 JP5546087B2 (ja) | 2014-07-09 |
Family
ID=36981996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005036235A Expired - Fee Related JP5546087B2 (ja) | 2005-02-14 | 2005-02-14 | 皮膚疾患経口治療または予防剤 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP5546087B2 (enExample) |
| CN (1) | CN101019853B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006306813A (ja) * | 2005-04-28 | 2006-11-09 | Suntory Ltd | 肥満細胞増殖抑制剤 |
| JP2006306812A (ja) * | 2005-04-28 | 2006-11-09 | Suntory Ltd | 好酸球浸潤抑制剤 |
| EP3581178B1 (en) | 2005-02-14 | 2023-08-30 | Suntory Holdings Limited | Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient |
| GB0907413D0 (en) * | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
| WO2012153832A1 (ja) | 2011-05-12 | 2012-11-15 | 日本水産株式会社 | 炎症性疾患用皮膚外用組成物 |
| US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
| JP2014530841A (ja) * | 2011-10-19 | 2014-11-20 | ディグニティサイエンシスリミテッド | Ｄｇｌａおよび／または１５−ｈｅｔｒｅを含む医薬組成物、ならびにその使用方法 |
| US9855236B2 (en) | 2011-10-19 | 2018-01-02 | Ds Biopharma Limited | Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof |
| AU2014358145C1 (en) | 2013-12-04 | 2022-09-15 | Nippon Suisan Kaisha, Ltd. | Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil |
| JP2017516823A (ja) | 2014-06-04 | 2017-06-22 | ディグニティ サイエンシス リミテッド | Ｄｇｌａを含む薬学的組成物及びその使用 |
| JP2019501190A (ja) * | 2016-01-07 | 2019-01-17 | ディーエス バイオファーマ リミテッド | Ｄｇｌａを含む薬学的組成物及びその使用 |
| CN109152759A (zh) * | 2016-06-01 | 2019-01-04 | 雀巢产品技术援助有限公司 | 用于预防变应性疾病的组合物 |
| CN110996937A (zh) * | 2017-05-19 | 2020-04-10 | Ds生物制药有限公司 | 包含dgla的药物组合物及其用途 |
| WO2020138480A1 (ja) * | 2018-12-28 | 2020-07-02 | 日本水産株式会社 | アラキドン酸含量が低減されたジホモ－γ－リノレン酸含有微生物油 |
| EP4039326A4 (en) * | 2019-10-01 | 2023-08-02 | Suntory Holdings Limited | COMPOSITION FOR IMPROVING INTESTINAL FUNCTION BY REGULATING THE EXPRESSION OF AQUAPORINE 3, AND THEIR USE |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
| JP2023058456A (ja) * | 2021-10-13 | 2023-04-25 | 花王株式会社 | 抗アレルギー剤 |
| EP4417200A4 (en) * | 2021-10-13 | 2025-10-15 | Kao Corp | AGENT FOR THE PREVENTION, TREATMENT OR ALLEVIATION OF INFLAMMATORY SKIN DISEASE |
| JPWO2023181755A1 (enExample) * | 2022-03-22 | 2023-09-28 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE47777B1 (en) * | 1978-01-23 | 1984-06-13 | Efamol Ltd | Pharmaceutical and dietary composition comprising gamma-linolenic acids |
| IE49783B1 (en) * | 1979-05-18 | 1985-12-11 | Efamol Ltd | Pharmaceutical and dietary composition comprising epsilon-linolenic acids |
| GB8806737D0 (en) * | 1988-03-22 | 1988-04-20 | Efamol Holdings | Therapeutic composition & method |
| JP2002047176A (ja) * | 2000-08-04 | 2002-02-12 | Idemitsu Technofine Co Ltd | ＩｇＥ産生抑制剤 |
-
2005
- 2005-02-14 JP JP2005036235A patent/JP5546087B2/ja not_active Expired - Fee Related
-
2006
- 2006-02-14 CN CN 200610003112 patent/CN101019853B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006219454A5 (enExample) | ||
| CA2549103C (en) | Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof | |
| ES2369074T3 (es) | Composiciones que tienen efectos preventivos o mejoradores de síntomas o enfermedades provocados por una hipofunción cerebral. | |
| HU226673B1 (en) | Use of essential fatty acids and bioactive disulphides for the preparation of therapeutic and dietary compositions | |
| JP2007523049A5 (enExample) | ||
| US9687462B2 (en) | Sn-2-monoacylglycerols and lipid malabsorption | |
| WO2009091538A8 (en) | Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia | |
| NZ600740A (en) | Compositions containing pufa and/or uridine and methods of use thereof | |
| SG10201400685SA (en) | Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia | |
| JP2021508321A (ja) | 睡眠及び気分障害の治療及び／又は改善における使用のための組成物 | |
| JP7346421B2 (ja) | 睡眠及び気分障害の治療及び／又は改善における使用のための組成物 | |
| RU2771277C2 (ru) | Лечение травматического повреждения головного мозга | |
| JP4633048B2 (ja) | 日内リズム正常化組成物 | |
| TW201110995A (en) | Oral composition for alleviation of ultraviolet radiation-induced damage | |
| JP2006306812A5 (enExample) | ||
| KR20190050016A (ko) | 오메가-3을 유효성분으로 포함하는 안구 건조증의 예방 또는 개선용 건강 기능성 식품조성물 | |
| US20160263072A1 (en) | Monoacylglycerols and fat-soluble nutrients for use in the treatment of malabsorption having a non-mechanical basis | |
| JP2007326799A5 (enExample) | ||
| WO2012043185A1 (ja) | Ｉｌ－８発現抑制組成物 | |
| JP4852296B2 (ja) | 血管炎症候群予防・治療剤 | |
| CA2427289A1 (en) | Fat composition and hexacosanoic acid depressant for oral or enteral administration | |
| JP2009084244A (ja) | 皮膚バリア機能改善剤等 | |
| RU99106551A (ru) | Применение арахидоновой кислоты и/или докозагексаеновой кислоты для получения лекарства для лечения диспраксии | |
| JP2007230912A (ja) | 神経再生促進剤、および該促進剤を含む機能性食品 | |
| JP2006254885A (ja) | 花粉症を改善及び予防する飲食物 |